to develop an easy-to-use

in-vitro diagnostics device

for professionals at the point of care

to rapidly and accurately monitor

specific chronic diseases


Radisens is developing a novel in-vitro diagnostics platform for point-of-care use. It targets the use of a finger-stick blood sample avoiding the need for venepuncture; integration of all sample preparation steps on the test cartridge; laboratory analyser equivalence; and extended …


The Radisens point-of-care platform – Gemini™ – uses a novel centrifugal microfluidic cartridge approach combined with proprietary dried reagent assay protocols based on immuno-turbidimetric and clinical chemistry principles. The Gemini™ point-of-care reader automatically …


Radisens has a business to business commercial approach with the aim to develop partnerships including technology licensing, development, manufacture and supply with collaborators in decentralised chronic disease monitoring and related markets.